Currently out of the existing stock ratings of Jack Wallace, 27 are a BUY (87.1%), 4 are a HOLD (12.9%).

Jack Wallace

Work Performance Price Targets & Ratings Chart

Analyst Jack Wallace, carries an average stock price target met ratio of 59.58% that have a potential upside of 26.96% achieved within 171 days. Previously, Jack Wallace worked at GUGGENHEIM.

Jack Wallace’s has documented 58 price targets and ratings displayed on 8 stocks. The coverage was on Consumer Defensive, Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on VEEV, Veeva Systems at 30-Sep-2024.

Wall Street Analyst Jack Wallace

Analyst best performing recommendations are on PHR (PHREESIA).
The best stock recommendation documented was for PHR (PHREESIA) at 12/6/2023. The price target of $22 was fulfilled within 8 days with a profit of $4.12 (23.04%) receiving and performance score of 28.8.

Average potential price target upside

HIMS Hims Hers Health PHR Phreesia VEEV Veeva Systems AMWL American Well Corp HCAT Health Catalyst NXGN Nextgen Healthcare RCM R1 RCM WW WW International

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 11-Sep-2026

$32

$3.93 (14.00%)

$33

1 months 10 days ago
(11-Sep-2026)

2/3 (66.67%)

$4.49 (16.32%)

46

Hold Since 07-Sep-2022

$32

$3.93 (14.00%)

$27

1 months 27 days ago
(24-Aug-2026)

26/30 (86.67%)

$0.92 (2.96%)

177

Buy Since 17-Jun-2026

$35

$6.93 (24.69%)

$39

2 months ago
(21-Aug-2026)

15/18 (83.33%)

$1.22 (3.61%)

88

Hold Since 12-May-2026

$33

$4.93 (17.56%)

$35

2 months 10 days ago
(11-Aug-2026)

27/29 (93.1%)

$2.49 (8.16%)

293

Hold Since 10-Mar-2022

$26

$-2.07 (-7.37%)

$28

2 months 10 days ago
(11-Aug-2026)

11/12 (91.67%)

$-4.51 (-14.78%)

78

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?